|
FOI Request 2125 - Drug Treatments |
|
Written by FOI Lead
|
| Case Number |
2125 |
| Request Date |
05/07/2010 |
|
Details of the Request
We are looking for the number of patients currently being treated in your Trust with the drugs:
For the conditions:
- chronic myeloid leukaemia (CML)
- gastrointestinal, stromal tumour (GIST),
- renal cell carcinoma (RCC)
|
|
| Completion Date |
14/04/2010 |
|
Details of the Response
Thank you for your request to Ashford and St. Peter’s Hospitals NHS Trust regarding Oncology Drugs (specifically Sprycel).
The Trust’s Chief Pharmacist has amended the table as follows:
| Drug |
CML |
GIST |
RCC |
| Glivec (Novartis) |
23 |
0 |
0 |
| Sutent (Pfizer) |
0 |
0 |
0 |
| Sprycel (Novartis) |
4 |
0 |
0 |
| Tasigna (Novartis) |
0 |
0 |
0 |
|
|
|
|
|
Last Updated ( Thursday, 19 May 2011 12:18 )
|
FOI Responses 
